Statistically significant improvements observed across clinical endpoints; final cohort results expected in Q2 2025 ...

Lipella Pharmaceuticals Abstract on Oral Lichen Planus Treatment Accepted for Podium Presentation at 2025 AAOM/EAOM International Meeting Conference on “Global Transformation in Oral Medicine” ...

Second Cohort Results Highlight Efficacy Across All Key Measures and Reinforce Safety of Twice-Daily Oral RinsePhase 2a Study Now Fully Enrolled ...

Lipella Pharmaceuticals (LIPO) announced topline results from the second cohort of its Phase 2a multicenter, dose-ranging trial evaluating ...

Lipella Pharmaceuticals Inc. (Nasdaq: LIPO) (“Lipella” or the “Company”), a clinical-stage biotechnology company focused on developing innovative therapies for unmet medical needs, today announced the ...

It did not have a significantly different therapeutic efficacy from the commercial paste dosage form in the treatment of oral lichen planus. Buffering agents and an antioxidant should be added to ...

The post Lipella Reports Additional Positive Data from Phase 2a Trial of LP-310 in Oral Lichen Planus appeared first on PRISM MarketView.

This is known as the isomorphic response or Koebner phenomena. Varients of lichen planus are presented in Figures 2-9. Treatment: There is no cure for lichen planus but treatment often relieves ...

Lichenification occurs when repeated scratching or rubbing causes skin to thicken and become leathery. Certain skincare and treatment options may help reduce the reaction.

Repeatedly scratching an area can cause lichenification, which is thickened, rough, and dark skin. The name comes from its resemblance to lichen, a plant-like growth found on rocks and trees.

“The completion of enrollment in our Phase 2a trial marks an important step in advancing a non-steroidal, locally delivered treatment for oral lichen planus, an underserved condition with no FDA ...